カレントテラピー　35-5　サンプル page 14/32

このページは カレントテラピー　35-5　サンプル の電子ブックに掲載されている14ページの概要です。
秒後に電子ブックの対象ページへ移動します。
「電子ブックを開く」をクリックすると今すぐ対象ページへ移動します。

概要：
カレントテラピー　35-5　サンプル

Current Therapy 2017 Vol.35 No.5 61双極性障害研究の最前線465blood cytokine network alterations in psychiatric patients：comparisons between schizophrenia, bipolar disorder anddepression. Mol Psychiatry 21：1696-1709, 201611）Fernandes BS, Steiner J, Molendijk ML, et al：C-reactiveprotein concentrations across the mood spectrum in bipolardisorder：a systematic review and meta -analysis. LancetPsychiatry 3：1147-1156, 201612）水流添覚，西川武志，荒木栄一：酸化ストレスとインスリン抵抗性．糖尿病 49：845-848, 200613）Brown NC, Andreazza AC, Young LT：An updated metaanalysisof oxidative stress markers in bipolar disorder. PsychiatryRes 218：61-68, 201414）Sullivan PF, Fan C, Perou CM：Evaluating the comparabilityof gene expression in blood and brain. Am J Med Genet BNeuropsychiatr Genet 141B：261-268, 200615）Rollins B, Martin MV, Morgan L, et al：Analysis of wholegenome biomarker expression in blood and brain. Am J MedGenet B Neuropsychiatr Genet 153B：919-936, 201016）Seifuddin F, Pirooznia M, Judy JT, et al：Systematic reviewof genome-wide gene expression studies of bipolar disorder.BMC Psychiatry 13：213, 201317）Matsubara T, Funato H, Kobayashi A, et al：Reduced GlucocorticoidReceptor alpha Expression in Mood DisorderPatients and First-Degree Relatives. Biol Psychiatry 59：689-695, 200618）Padmos RC, Hillegers MH, Knijff EM, et al：A discriminatingmessenger RNA signature for bipolar disorder formed by anaberrant expression of inflammatory genes in monocytes.Arch Gen Psychiatry 65：395-407, 200819）Munkholm K, Vinberg M, Berk M, et al：State-related alterationsof gene expression in bipolar disorder：a systematicreview. Bipolar Disord 14：684-696, 201220）渡辺義文，内田周作，大朏孝治ほか：気分障害のバイオマーカー開発，とくに白血球での遺伝子発現からみた気分障害の状態診断，亜型分類．精神誌 114：812-820, 201221）Witt SH, Juraeva D, Sticht C, et al：Investigation of manicand euthymic episodes identifies state -and trait -specificgene expression and STAB1 as a new candidate gene forbipolar disorder. Transl Psychiatry 4：e426, 201422）Kato T, Hayashi-Takagi A, Toyota T, et al：Gene expressionanalysis in lymphoblastoid cells as a potential biomarker ofbipolar disorder. J Hum Genet 56：779-783, 201123）Munkholm K, Peijs L, Vinberg M, et al：A composite peripheralblood gene expression measure as a potential diagnosticbiomarker in bipolar disorder. Transl Psychiatry 5：e614,201524）Weaver IC, Champagne FA, Brown SE, et al：Reversal ofmaternal programming of stress responses in adult offspringthrough methyl supplementation：altering epigenetic markinglater in life. J Neurosci 25：11045-11054, 200525）Roth TL, Lubin FD, Funk AJ, et al：Lasting epigenetic influenceof early-life adversity on the BDNF gene. Biol Psychiatry65：760-769, 200926）Sugawara H, Iwamoto K, Bundo M, et al：Hypermethylationof serotonin transporter gene in bipolar disorder detected byepigenome analysis of discordant monozygotic twins. TranslPsychiatry 1：e24, 201127）Fries GR, Li Q, McAlpin B, et al：The role of DNA methylationin the pathophysiology and treatment of bipolar disorder.Neurosci Biobehav Rev 68：474-488, 201628）Teroganova N, Girshkin L, Suter CM, et al：DNA methylationin peripheral tissue of schizophrenia and bipolar disorder：a systematic review. BMC Genet 17：27, 201629）Numata S, Ishii K, Tajima A, et al：Blood diagnostic biomarkersfor major depressive disorder using multiplex DNAmethylation profiles：discovery and validation. Epigenetics10：135-141, 201530）Fries GR, Pfaffenseller B, Stertz L, et al：Staging and neuroprogressionin bipolar disorder. Curr Psychiatry Rep 14：667-675, 2012